Artiva Biotherapeutics, Inc. Common Stock Strategic Asset Allocation Index
Artiva Biotherapeutics, Inc. Common Stock strategic asset allocation index. Artiva Biotherapeutics, Inc. Common Stock (ARTV) has a Strategic Asset Allocation Index of 26.4% as of September 2024. Strategic assets (PP&E of $- plus long-term investments of $52.97 Million) total $52.97 Million, measured against net assets of $201.00 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Artiva Biotherapeutics, Inc. Common Stoc (ARTV) tangible net worth to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Artiva Biotherapeutics, Inc. Common Stock Strategic Asset Allocation Index by Year (None–None)
Artiva Biotherapeutics, Inc. Common Stock strategic asset allocation index by year from None to None. The table below presents the year-by-year Strategic Asset Allocation Index for Artiva Biotherapeutics, Inc. Common Stock from None to None, covering 0 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see ARTV market cap.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|